M
Michael Levy
Neurologist and director of the NMO Clinic and Research Laboratory at Massachusetts General Hospital; associate professor at Harvard Medical School.
11
APPEARANCES
9
PODCASTS
024
DEC 30
JAN 6
JAN 13
JAN 20
JAN 27
FEB 3
FEB 10
FEB 17
FEB 24
MAR 3
MAR 10
MAR 17
MAR 24
MAR 31
APR 7
APR 14
APR 21
APR 28
MAY 5
MAY 12
MAY 19
MAY 26
JUN 2
JUN 9
JUN 16
JUN 23
JUN 30
JUL 7
JUL 14
JUL 21
JUL 28
AUG 4
AUG 11
AUG 18
AUG 25
SEP 1
SEP 8
SEP 15
SEP 22
SEP 29
OCT 6
OCT 13
OCT 20
OCT 27
NOV 3
NOV 10
NOV 17
NOV 24
DEC 1
DEC 8
DEC 15
DEC 22
DEC 29
JAN 5
JAN 12
JAN 19
JAN 26
FEB 2
FEB 9
FEB 16
FEB 23
MAR 2
MAR 9
MAR 16
MAR 23
MAR 30
APR 6
APR 13
APR 20
APR 27
MAY 4
MAY 11
MAY 18
MAY 25
JUN 1
JUN 8
JUN 15
JUN 22
JUN 29
JUL 6
JUL 13
JUL 20
JUL 27
AUG 3
AUG 10
AUG 17
AUG 24
AUG 31
SEP 7
SEP 14
SEP 21
SEP 28
OCT 5
OCT 12
OCT 19
OCT 26
NOV 2
NOV 9
NOV 16
Oct 2, 2026
October 2026 Recall: Updates in Immune-Based Therapies for Neurologic Disease
25:56
M
21:52Michael LevyGUEST
Yeah, so this trial is based on a small series of cases that were treated with the older version of satralizumab called tocilizumab.

Shubhra RoyHOST
For providers who may be a little bit less familiar with satchelizumab, if a patient were to ask, what are the risks associated with this treatment? What counsel would you give them?
Florida & Alaska Primaries, Iran War Strains, and AOC on “Woke 1”
M
48:21Michael LevyGUEST
So I was I was thinking about this as you were talking, and I'll just say one snarky thing first around, you know, Republicans holding Democrats to every wild outlandish thing that some activists said online or some slogan that only a very small percentage said.
M
48:39Michael LevyGUEST
I can't wait to hear how when the Democrats come back into the White House in 2029, the Republicans are going to somehow get religion again on the national debt and reducing the $40 trillion in debt that we're in.
M
48:54Michael LevyGUEST
And although I hate AOC, you know, that we're talking about this and doing it in software releases for progressive politics of 1.0 and 2.0 and 2.1 and all of that kind of stuff.
M
49:04Michael LevyGUEST
But defund the police was an atrocious slogan for Democrats, even if it was still a small sliver of the Democratic activist base that actually was talking about it.
M
49:17Michael LevyGUEST
Because, you know, when we look at the National Guard, and I was sad that you weren't there to discuss it last week with us, Michael, And Trey and I talked about the National Guard deployment, because if you ask, you know, talk about defund the police and then you ask real people in neighborhoods that are afflicted by crime, like even though they might not want armed police who are responding to every mental health crisis or every homeless situation and rather have different kinds of professionals dealing with that.
Why are some people microdosing weight loss drugs?
15:42
20:34

Claudia HammondHOST
And so where did the idea come from that Epstein-Barr virus could be linked to multiple sclerosis?
M
15:48Michael LevyGUEST
Well, it, it took a long time to wrap people's heads around this idea because if everyone gets Epstein-Barr virus, then why do only a few people, one in three or 400, get MS? It doesn't really compute.
M
16:01Michael LevyGUEST
And so that's really limited the field for a very long time until a really good study in 2022 demonstrated that without exposure to the Epstein-Barr virus, you cannot get MS.
M
16:14Michael LevyGUEST
And this was a study done in the US military where everyone at age 18 who enrolls in the military gets a blood draw.
M
16:21Michael LevyGUEST
And what they did was they looked at everyone who was initially negative, who'd not yet gotten exposed to the virus, and they pooled all of those samples of people who would eventually get MS and of those who didn't.
M
16:35Michael LevyGUEST
And the ones who got MS invariably got the Epstein-Barr virus infection first and then evidence that there was neurological damage and then clinical onset of MS.

Claudia HammondHOST
What about trying to prevent people from getting the Epstein-Barr virus in the first place so that they can't then go on to develop MS? Could you see a day when we have a vaccine against it?
Reindustrialization, Data Center Gold Rush, Death of The Allocator, National Security, & Capital Flows with Michael Levy (#425)
M
0:50Michael LevyGUEST
Okay, let's step way back from the real estate business, and really let's talk, talk about society and our economy and, you know, what's happening in the world that we live in, in the great arc of history, right? The big arcs.
M
1:04Michael LevyGUEST
There's the really big arcs of history, which are hundreds of years, millennials, and you talk about empires falling and declining.
M
1:14Michael LevyGUEST
And this is just something that's been on my mind for the past couple of years and affecting the way I think about the world and affecting our, our company and our business.
M
1:23Michael LevyGUEST
When I went to college, which is well in advance of you going to college, it was, I wouldn't say the very beginning, but it really was near the, the, the beginning of let's outsource everything.
M
1:34Michael LevyGUEST
Um, we were taught that, right? Guns and butter, move everything to where it was the lowest cost provider and the competitive advantages that they had.
59 MINS LATER
Ask the Expert 1410. Understanding Optic Neuritis | Causes, Treatments, and Repair
M
6:30Michael LevyGUEST
Well, usually people present to an ophthalmologist because they're thinking there's something wrong with their vision.
M
6:36Michael LevyGUEST
As Dr. Greenberg was saying, most of the time the eye looks fine to the ophthalmologist.
M
6:41Michael LevyGUEST
But since the patient can't see well out of the eye, then the ophthalmologist figures, okay, there must be something wrong with the nerves behind the eye that they can't see.
M
6:49Michael LevyGUEST
So then they send them to the emergency room or to a neuro-ophthalmologist or a neurologist.
9 MINS LATER
ABCs of NMOSD 702. CAR-T in NMOSD
M
4:51Michael LevyGUEST
Yeah, I think a lot of our patients have been on rituximab or a blizna and a blizumab, and they're familiar with the role of B cells.
M
5:00Michael LevyGUEST
And B cells that can produce plasma blasts that make aquaporin-4 antibodies, these immune components are all different.
M
5:10Michael LevyGUEST
involved in the pathology of NMOSD and removing them, removing B cells specifically is helpful.
M
5:17Michael LevyGUEST
That's been, we've been using rituximab since 2005 for NMOSD and anabolizumab since I think 2020.
Couple faces charges after scaling the Empire State Building | Jesse Weber Live Full Show 7/1
21:54
23:38

Jesse WeberHOST
And are you concerned that people will try to do something like this in the future? Because it appears incredibly dangerous, particularly to do without equipment.
M
22:11Michael LevyGUEST
But in the social media age and in the age of free solo and death-defying stunts like that, I think that it probably does bring attention, but again, a negative attention, as you kind of say.
M
22:29Michael LevyGUEST
They're trying to get whatever they are looking to get out of nature or the gym and exercise and this.
M
22:39Michael LevyGUEST
Ultimately, they're getting very high off the ground and it's very dangerous, but it has very little to do with rock climbing.

Jesse WeberHOST
But let me ask you, like, climbing a skyscraper, particularly with no equipment, let's say that's what we're talking about, or even with equipment, how is that different from any other kind of structure?
Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD
1:28
M
1:04Michael LevyGUEST
This was a phase three placebo-controlled blinded study that enrolled 132 participants, randomized one-to-one to either drug or placebo, and followed over a period of about two years.
M
1:19Michael LevyGUEST
And the outcome is that Satchelizumab prevented relapses by about 68% compared to background therapy.

Shuvro RoyHOST
And can you take us through the context of what this means for patients with MOG antibody disease moving forward?
M
1:35Michael LevyGUEST
This is the first phase three trial that read out in MOG antibody disease, and it'll probably be the first FDA approved drug for MOG
Advancing MOGAD Care
3:48

Peter SguignaHOST
Now, this agent, the satchelizumab, is an FDA-approved drug for other conditions, but were there any new safety concerns when it was studied in this population?
M
4:04Michael LevyGUEST
It is approved for aquaporin-4-seropositive neuromyelitis optica spectrum disorder.
M
4:09Michael LevyGUEST
People may recognize the older version of satralizumab, which is called tocilizumab, which is approved for arthritis, rheumatoid arthritis, juvenile rheumatoid arthritis, and vasculitis.
M
4:22Michael LevyGUEST
The newer version, satralizumab, which is approved for NMOSD, is monthly, and it's a subcutaneous injection.
M
4:30Michael LevyGUEST
In the trial for NMOSD, and now we have over five years of safety data, the side effects have been relatively mild.
Safety and Efficacy of Satralizumab in Patients with Relapsing MOGAD
7:31
M
3:27Michael LevyGUEST
So this trial is based on a small series of cases that were treated with the older version of satralizumab called tocilizumab.
M
3:46Michael LevyGUEST
It's over fifteen years old now, and there are biosimilars available, and so we have been able to use it off-label.

Shubhra RoyHOST
For providers who may be a little bit less familiar with satralizumab, if a patient were to ask, "What are the risks associated with this treatment?" what counsel would you give them?
3.13.25 The viability of the CFPB, the recuperation of a former hostage, and raising a child with medical needs
T
16:04Travis KircherCORRESPONDENT
He also confirms that Hamas gave some of the hostages, for lack of a better term, a grab bag before they were handed over to the Red Cross.
M
16:25Michael LevyGUEST
The only thing Or got was a certificate, but I know that from o- other hostages that were released that, uh, some of them got, uh, pictures of, uh, the city of Gaza, a scarf of Hamas, or a headband of Hamas, or something like that.
T
19:45Travis KircherCORRESPONDENT
Michael says it was an emotional moment for both his brother and the team.


